Pricing Log in Create free account
Friday 6 November 2026 Export SHC’s income statement to Excel — free account

Sotera Health Company

SHC Healthcare Diagnostics & Research

Sotera Health Company’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 5.74% from fiscal 2024.

Revenue
+4.36%
EPS
+20.1%
Free cash flow
+65.0%
Total debt
+0.14%

Quarter to September 2026, against a year earlier

15.87 0.52 −3.17%
Market cap
$4.5B
P/E
26.3×
Fwd P/E
26.4×
Dividend yield
—
F-score
7/9
Altman Z
1.76
Beneish M
−2.75
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Sotera Health Company (SHC) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, Sotera Health Company (SHC) trades at a EV/EBITDA of 11.9×. Over the past ten years it has ranged from 8.1× (November 2022) to 26.7× (December 2020); the current reading is higher than 19% of that period. That is below the Diagnostics & Research industry median of 23.4× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 13.7× 8.48%
FY2024 12.6× (15.92%)
FY2023 15.0× 55.83%
FY2022 9.6× (51.81%)
FY2021 20.0× (17.31%)
FY2020 24.2× (2.65%)
FY2019 24.8× 0.00%
FY2018 24.8× —

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 13.3× 1.13%
Jun 2026 13.1× 12.05%
Mar 2026 11.7× (14.52%)
Dec 2025 13.7× 5.41%
24 more quarters

Against its own ten years

Low 8.1× High 26.7×
Ten-year median 14.1×
Current reading's percentile 19

EV/EBITDA against peers

Company EV/EBITDA
GRAL GRAIL, Inc. compare n/m
ADPT Adaptive Biotechnologies Corporation compare n/m
VCYT Veracyte, Inc. compare 11.8×
SHC Sotera Health Company 11.9×
QGEN QIAGEN N.V. compare 17.4×
RDNT RadNet, Inc. compare 21.8×
CDNA CareDx, Inc. compare 26.6×
BLLN BillionToOne, Inc. compare 86.7×
NEO NeoGenomics, Inc. compare 147×
Diagnostics & Research industry median 23.4×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on SHC